Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of α-Amylase, α-Glucosidase, Pancreatic Lipase, 15-Lipooxygenase and Acetylcholinesterase Modulated by Polyphenolic Compounds, Organic Acids, and Carbohydrates of Prunus domestica Fruit. | Antioxidants (Basel) | 2023 | 37507919 | PubTator, text mining | PubMed |
| Mechanistic Understanding of Idiosyncratic Drug-Induced Hepatotoxicity Using Co-Cultures of Hepatocytes and Macrophages. | Antioxidants (Basel) | 2023 | 37507855 | PubTator, text mining | PubMed |
| Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity. | Clin Proteomics | 2023 | 37501157 | PubTator, text mining | PubMed |
| A Panoramic View of Ferroptosis in Cardiovascular Disease. | Kidney Dis (Basel) | 2023 | 37497204 | PubTator, text mining | PubMed |
| Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma. | Cell Death Dis | 2023 | 37495601 | PubTator, text mining | PubMed |
| Mercury accumulation and biomarkers of exposure in two popular recreational fishes in Hawaiian waters. | Ecotoxicology | 2023 | 37491684 | PubTator, text mining | PubMed |
| Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives. | Eur J Med Chem | 2023 | 37482018 | PubTator, text mining | PubMed |
| Thioredoxin reductase-1 and incidence of COVID-19 among cholangiocarcinoma patients in tropical endemic area. | J Cancer Res Ther | 2023 | 37470626 | PubTator, text mining | PubMed |
| Methodological and Cellular Factors Affecting the Magnitude of Breast Cancer and Normal Cell Radiosensitization Using Gold Nanoparticles. | Int J Nanomedicine | 2023 | 37457801 | PubTator, text mining | PubMed |
| Therapeutic potential of curcumin and its nanoformulations for treating oral cancer. | World J Methodol | 2023 | 37456978 | PubTator, text mining | PubMed |
| A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses. | Front Oncol | 2023 | 37456238 | PubTator, text mining | PubMed |
| Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis. | Molecules | 2023 | 37446864 | PubTator, text mining | PubMed |
| Insights into the Antioxidant/Antiradical Effects and In Vitro Intestinal Permeation of Oleocanthal and Its Metabolites Tyrosol and Oleocanthalic Acid. | Molecules | 2023 | 37446813 | PubTator, text mining | PubMed |
| Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment. | Int J Mol Sci | 2023 | 37446140 | PubTator, text mining | PubMed |
| Endogenous and Exogenous Regulation of Redox Homeostasis in Retinal Pigment Epithelium Cells: An Updated Antioxidant Perspective. | Int J Mol Sci | 2023 | 37445953 | PubTator, text mining | PubMed |
| Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. | Int J Mol Sci | 2023 | 37445737 | PubTator, text mining | PubMed |
Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial. | Cells | 2023 | 37443807 | PubTator, text mining | PubMed |
| GPX4 is a key ferroptosis biomarker and correlated with immune cell populations and immune checkpoints in childhood sepsis. | Sci Rep | 2023 | 37443372 | PubTator, text mining | PubMed |
| Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | 37434092 | PubTator, text mining | PubMed |
| NOS inhibition reverses TLR2-induced chondrocyte dysfunction and attenuates age-related osteoarthritis. | Proc Natl Acad Sci U S A | 2023 | 37428931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=28